openPR Logo
Press release

Automated External Defibrillator Market is Expected to Reach US$ 15 Billion by 2022

The Global Automated External Defibrillator Market is segmented on the lines of its type, end user and regional. Based on type segmentation it covers semi automated external defibrillator and fully automated external defibrillator. Under end user segmentation it covers home based, hospitals and pre hospitals.

Browse Full Report @: https://www.marketresearchengine.com/reportdetails/automated-external-defibrillator-market

How Big is the Global Automated External Defibrillator?

The Global Automated External Defibrillator Market is expected to exceed more than US$ 15 billion by 2022 and will grow at a CAGR of more than 7% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GE Healthcare, Philips Healthcare, Boston Scientific, Nihon Kohden, St. Jude Medical, Biotronik, Zoll Medical, Mindray, Cardiac Science, Physio Control and Primedic. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The global automated external defibrillator market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Defibrillators Market, By Product
8 Defibrillators Market, By End User
9 Global Defibrillators Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Introduction
11.1.1 Geographic Benchmarking
11.2 Medtronic PLC
11.3 St. Jude Medical, Inc.
11.4 Boston Scientific Corporation
11.5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
11.6 Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
11.7 Biotronik Se & Co.Kg
11.8 Physio-Control International, Inc.
11.9 Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
11.10 Sorin Group (Now Livanova PLC)
11.11 Nihon Kohden Corporation

About MarketResearchEngine

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Automated External Defibrillator Market is Expected to Reach US$ 15 Billion by 2022 here

News-ID: 604923 • Views: 274

More Releases from Market Research Engine Reports - MRE

Medical Image Analysis Software Market is Expected to Exceed US$ 3.3 Billion by …
The global medical image analysis software market by software type is segmented as integrated software and standalone software. According to its image types the market is further segmented in to 2D, 3D and 4D imaging. The market is further segmented according to its modality such as tomography, ultrasound imaging, radiography imaging and combined modalities. The application segment consists of orthopedic, dental, neurology, cardiology, oncology, obstetrics and gynecology, mammography and urology
Pharmacovigilance Market will Rise at a CAGR of 13% During the Forecast, by 2020
The global pharmacovigilance market according to clinical trial phase is segmented aspre-clinical, Phase I, Phase II, Phase IIIandPhase IV. The type of service provider segment consists of In-House and contract outsourcing. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World(ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market How Big is the Global Pharmacovigilance Market? Global pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue
Biomarkers Market is Expected Exceed US$ 60.0 Billion by 2023
The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing
Neuromodulation Market is Expected to Reach US$ 11 Billion by 2022
The Global Neuromodulation Market is segmented on the lines of its technology, application and biomaterial. Technology segmentation is further classified into internal neuromodulation and external neuromodulation. Based on internal neuromodulation segmentation it covers deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Based on application segmentation it covers chronic pain

All 5 Releases


More Releases for Defibrillator

Medical Defibrillator(Monophasic)
Asynchronizer:External defibrillator Charging time:At 360J less than 10 sec Paddle configuration:Reusable extermal adult and pediatric paddles Operates from the mains (AC) and with its intemal Lead-acid battery Jiangsu Medwish Network Technology Co., Ltd. is located in Jiangsu, China. It is in a beautiful, clean and convenient environment. We are a professional manufacturer engaged in the research, development, production, sales and export of medical equipment. At the same time, we have a professional foreign
Fully Automatic External Defibrillator Market
https://www.qandqmarketresearch.com/reports/7228183/fully-automatic-external-defibrillator-market-79 The global Fully Automatic External Defibrillator market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 20182025. The objectives of this study are to define, segment, and project the size of the Fully Automatic External Defibrillator market based on company, product type, end user and key regions. This report studies the global market size
Global Cardiac Defibrillator Sales Market Report 2017
Global Cardiac Defibrillator Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. This report on the global Cardiac Defibrillator market presents an outline of the market from the perspective of key segments, forces defining market’s overall development, and scope of growth on global and regional levels in the next few years. The report is a rich data repository including vast
Global Defibrillators Market, By Product Type (Single Chamber Implantable Cardio …
Defibrillators – Never Skip a Beat Defibrillator is an essential tool in cardiopulmonary resuscitation indicated in cardiac arrhythmia. Various advancements have been observed in defibrillator technology – from manual to automated ones, and implantable defibrillators to ensure constant care for patients suffering from ischemic heart disease or those at high risk of cardiac arrest. A Global Resuscitation Alliance (GRA) was formed in 2016, comprising international health organizations, global resuscitation leaders, and
Global Defibrillators Market, By Product Type (Single Chamber Implantable Cardio …
Defibrillation is a technique that is considered as a definitive treatment of cardiac arrests and arrhythmias. Defibrillators are devices that are used to defibrillate or stabilize the heartbeat of the patient in a condition of arrhythmias and ventricular tachycardia. Defibrillators work on the principle of electrical shock transfer to the chest area of the patient. This induces impulses to the heart membrane and favor the stability of the cardiac rhythm.
Global Defibrillators Market, By Product Type (Single Chamber Implantable Cardio …
Defibrillators – Never Skip a Beat Defibrillator is an essential tool in cardiopulmonary resuscitation indicated in cardiac arrhythmia. Various advancements have been observed in defibrillator technology – from manual to automated ones, and implantable defibrillators to ensure constant care for patients suffering from ischemic heart disease or those at high risk of cardiac arrest. A Global Resuscitation Alliance (GRA) was formed in 2016, comprising international health organizations, global resuscitation leaders, and